The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer

Several subsets of non-small cell lung cancer (NSCLC) are defined by the presence of oncogenic rearrangements that result in constitutive activation of a chimeric fusion protein. In NSCLCs that harbor ALK or ROS1 rearrangements, aberrant signaling from these fusion proteins can be overcome by potent...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transl Lung Cancer Res
Hoofdauteurs: Dagogo-Jack, Ibiayi, Ritterhouse, Lauren L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AME Publishing Company 2020
Onderwerpen:
Review Article on Looking for Chimeras in NSCLC: Widen Therapeutic Options Targeting Oncogenic Fusions
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7815348/
https://ncbi.nlm.nih.gov/pubmed/33489818
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-2019-cnsclc-09
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items